A randomized, open-label trial of iron isomaltoside 1000 (Monofer®) compared with iron sucrose (Venofer®) as maintenance therapy in haemodialysis patients

BACKGROUND: Iron deficiency anaemia is common in patients with chronic kidney disease, and intravenous iron is the preferred treatment for those on haemodialysis. The aim of this trial was to compare the efficacy and safety of iron isomaltoside 1000 (Monofer®) with iron sucrose (Venofer®) in haemodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhandari, Sunil, Kalra, Philip A., Kothari, Jatin, Ambühl, Patrice M., Christensen, Jeppe H., Essaian, Ashot M., Thomsen, Lars L., Macdougall, Iain C., Coyne, Daniel W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2015
Materias:
Clinical Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550440/
https://www.ncbi.nlm.nih.gov/pubmed/25925701
http://dx.doi.org/10.1093/ndt/gfv096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4550440/
https://www.ncbi.nlm.nih.gov/pubmed/25925701
http://dx.doi.org/10.1093/ndt/gfv096

Ejemplares similares